Cost-effectiveness of Check It: A Novel Community-Based Chlamydia Screening and Expedited Treatment Program for Young Black Men. (2nd December 2021)

• Record Type: Journal Article
• Authors: Stoecker, Charles; Monnette, Alisha; Qu, Zhuolin; Schmidt, Norine; Craig-Kuhn, Megan Clare; Kissinger, Patricia J
• Is Part Of: Clinical infectious diseases. Volume 74:Number 12(2022)
• Page Start: 2166
• Page End: 2172
• Publication Date: 2021-12-02
• Subjects: chlamydia -- screening -- expedited partner treatment -- cost-effective; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciab818
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Background: We assessed the cost-effectiveness of the Check It program, a novel community-based chlamydia screening and expedited partner treatment program for young Black men conducted in New Orleans since 2017. Methods: We implemented a probabilistic cost-effectiveness model using a synthetic cohort of 16 181 men and 13 419 women intended to simulate the size of the Black, sexually active population in New Orleans ages 15–24 years. Results: The Check It program cost $196 838 (95% confidence interval [CI]: $117 320–$287 555) to implement, saved 10.2 quality-adjusted life-years (QALYs; 95% CI: 7.7–12.7 QALYs), and saved $140 950 (95% CI: −$197 018 to −$105 620) in medical costs per year. The program cost $5468 (95% CI: cost saving, $16 717) per QALY gained. All iterations of the probabilistic model returned cost-effectiveness ratios less than $50 000 per QALY gained. Conclusions: The Check It program (a bundled seek, test, and treat chlamydia prevention program for young Black men) is cost-effective under base case assumptions. Communities where Chlamydia trachomatis rates have not declined could consider implementing a similar program. Abstract : A synthetic cohort study of a novel community-based chlamydia screening program with expedited partner treatment for young Black men in New Orleans found the program cost-effective.